Julia Kristiane Schmidt

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Wintershall Holding Gmbh, Basf Se Corporation. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia Kristiane Schmidt. Retrieved from https://idiyas.com/inventor/julia-kristiane-schmidt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 3)

% Patents Active = 60.0

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

5 out of 19

Wintershall Holding Gmbh

where one patent can have more than one assignee

Years Active: 2013-2016

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9388441 - Genetically modified microorganisms capable of producing β-glucans and methods for producing β-glucans (2016-07-12),

2. 9322041 - Genetically modified microorganisms capable of producing beta-glucans and methods for producing beta-glucans (2016-04-26),

3. 9206348 - Process for mineral oil production from mineral oil deposits with high deposit temperature (2015-12-08),

4. 8852750 - Method for the coating of a cellulose material by using a glucan (2014-10-07),

5. 8574873 - Process for the preparation of homopolysaccharides (2013-11-05),

Title: Julia Kristiane Schmidt: Innovator in Biotechnology

Introduction

Julia Kristiane Schmidt is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of genetically modified microorganisms. With a total of five patents to her name, her work focuses on enhancing the production of beta-glucans, which have various applications in health and industry.

Latest Patents

One of her latest patents involves genetically modified microorganisms capable of producing beta-glucans. This invention is characterized by the overexpression of a polynucleotide encoding a polypeptide with 1,3-β-D-glucan synthase activity. The patent outlines methods for increasing the expression of this polynucleotide, thereby improving the efficiency of beta-glucan production. This innovative approach has the potential to revolutionize the way beta-glucans are synthesized, making them more accessible for various applications.

Career Highlights

Throughout her career, Julia has worked with notable companies such as Wintershall Holding GmbH and BASF SE Corporation. Her experience in these organizations has allowed her to develop her expertise in biotechnology and contribute to groundbreaking research and development projects.

Collaborations

Julia has collaborated with esteemed colleagues, including Mari Granström and Rajan Hollmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing her contributions to the field.

Profile summary based on public USPTO records.